CDSCO Launches QR Code System for Visitor Registration

The Central Drugs Standard Control Organisation (CDSCO) has introduced a QR Code-based appointment booking for stakeholders visiting CDSCO’s headquarters located in the FDA Bhawan at New Delhi

Torrent Pharma to Launch Semaglutide Post Patent Expiry in 2026

Torrent Pharmaceuticals is preparing to launch semaglutide, both oral and injectable, once the patent for the drug expires in early 2026. This positions Torrent as one of the initial entries in the race for India's pharmaceutical players to get...

Alembic Receives USFDA Approval for Generic Epilepsy Drug

The US Food and Drug Administration has given Alembic Pharmaceuticals final approval to market its extended-release carbamazepine tablets in the US. Strengths of 100 mg, 200 mg, and 400 mg are covered by the approval.

EMA Panel Recommends Donanemab for Early Alzheimer Treatment

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended donanemab for the treatment of early symptomatic Alzheimer's disease in adults with confirmed amyloid pathology who are heterozygotes

Apollo partners with Siemens for AI-driven liver health innovation

Apollo Hospitals and Siemens Healthineers have announced a strategic research alliance to foster innovation in liver disease diagnostics leveraging artificial intelligence (AI) and imaging, with a focus on developing AI-enabled clinical tools

GSK signs $12B partnership with Hengrui Pharma for oncology push

GlaxoSmithKline (GSK) recently revealed that it had allied with Chinese Hengrui Pharma to co-develop up to 12 novel medicines. The collaboration was valued at potentially up to $12 billion and is intended to support GSK’s long-term growth

Akums Sterile Plant Gets ANVISA GMP Certification for Manufacturing

Akums Drugs & Pharmaceuticals Ltd., India’s largest contract manufacturing pharmaceutical company, is proud to announce that its Sterile Manufacturing Plant has received the prestigious Good Manufacturing Practice(GMP) Certificate from ANVISA...

India's First Affordable CAR-T Therapy Turns Profitable in a Year

In a major leap for India's biotech industry, accessible CAR-T therapy has not only reached patients sooner than expected but has also become commercially viable. ImmunoACT, the startup that created India's first indigenous CAR-T cell therapy...

AIOCD Seeks Crackdown on Illegal E-Pharmacies Amid Regulatory Void

The All India Organisation of Chemists and Druggists (AIOCD) is raising serious concerns about the unregulated modus operandi of illegal e-pharmacies in India. AIOCD sent a letter to the Drugs Controller General of India (DCGI) calling...

Wockhardt's Zaynich Featured in UK Journal After Clinical Success

In a remarkable boost for innovation in antibiotics, Wockhardt's Zaynich has been mentioned in a top medical journal in the UK following a remarkable recovery case of a liver transplant patient with a pan-drug-resistant infection...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.